The Role of the Diabetes Educator in Diabetes Formulary and Medical Device Decisions

Abstract

Get full access to this article

View all access options for this article.

References

Happe

Clark

Holliday

. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization. J Manag Care Spec Pharm. 2014;20(7):677-684.

Neumann

Cohen

JT.

Measuring the value of prescription drugs. N Engl J Med. 2015;373(27):2595-2597.

Karter

Ferrara

Darbinian

Ackerson

Selby

JV.

Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23(4):477-483.

Wintergerst

Hinkle

Barnes

Omoruyi

Foster

MB.

The impact of health insurance coverage on pediatric diabetes management. Diab Res Clin Prac. 2010;90:40-44.

Eby

Boye

Lage

MJ.

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study. J Med Econ. 2013;16(10):1231-1237.

Powers

Bardsley

Cypress

. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educator. 2017;43(1):40-53.

Academy of Managed Care Pharmacy. Formulary Management. 2009, November at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=9298. Accessed January 29, 2018.

AADE. The role of the diabetes educator in diabetes formulary and medical device decisions. https://www.diabeteseducator.org/practice/practice-documents/position-statements. Accessed February 27, 2018.